Associate Sponsors

Co-sponsor

Home / India News / Lupin signs agreement with Sunovion Pharmaceuticals Inc.

Lupin signs agreement with Sunovion Pharmaceuticals Inc.

Image
Capital Market
Last Updated : Oct 20 2022 | 11:16 AM IST
LinkedIN IconFacebook Icon
Lupin Inc., USA, wholly owned subsidiary of Lupin Ltd has signed Definitive Agreement with Sunovion Pharmaceuticals Inc., USA for acquiring Brovana and Xopenex HFA, respiratory brands for a total purchase price of 75 Million USD. The acquisition is expected to be completed 2-3 weeks post signing.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Connect with us on WhatsApp

More From This Section

Board of LIC accords approval for equity infusion in LIC (Lanka)

Bharat Aluminium successfully bids for Barra Coal Block in Chhattisgarh

Board of CG Power approves capex of Rs 230 for increasing capacity of LT motors

Mahindra Logistics allots 10,866 equity shares under RSU Plan

First Published: Oct 20 2022 | 11:05 AM IST

Explore News

Next Story